ru24.pro
News in English
Октябрь
2024

Новости за 04.10.2024

Spain’s Secuoya Studios Aims for English-Language Projects as It Unveils New Content Strategy

Variety 

Spain’s Secuoya Studios aims to produce more English-language projects as part of its new international strategy. Holding forth to a packed audience at the 4th Iberseries & Platino Industria confab, Secuoya Studios CEO Brendan Fitzgerald, introduced the company’s three new executive producers Mónica Aguirre, Sergio Cánovas and Juan Carballo, who will be leading the company’s […]

Ferencvaros 1-2 Spurs: Three Tottenham Talking Points

All Action, No Plot 

1. Team Selection AANP has prattled on a few times in recent weeks about the virtues of integrating up to a maximum of four non-regulars in a Starting XI, and conversely the vices of shoving in youths and extras until a Starting XI is bursting at the seams with lesser-seen faces, so I won’t bang […]

FA Trophy Previews

The Non-League Paper 

The Isuzu FA Trophy 3rd Qualifying Round takes place this weekend. Four games will be given extensive coverage in Sunday’s Non-League Paper, with a match report from every tie.

Читать дальше...

This new meme coin and Dogecoin's new rival has attracted the attention of crypto whales

Economictimes.indiatimes.com 

Cutoshi (CUTO) is emerging as a strong challenger to Dogecoin (DOGE), attracting interest due to its focus on decentralization and DeFi. It offers a community-driven ecosystem, a decentralised exchange, and income opportunities through its farming mechanism. With its ongoing presale, Cutoshi is positioned for potential significant growth, possibly surpassing Dogecoin by 2030.

Oxford University vaccine study gets funding - BBC.com

Top Stories (uk) - Google News (com) 

  1. Oxford University vaccine study gets funding  BBC.com
  2. World's first ovarian cancer vaccine being developed in UK 'could wipe out the disease'  Sky News
  3. Ovarian cancer vaccine study gets funding  BBC
  4. World-first vaccine created by Oxford scientists could wipe out ovarian cancer  Oxford Mail